Results 211 to 220 of about 174,816 (264)
Some of the next articles are maybe not open access.
Cancer Research, 2016
Abstract Cytotoxic lymphodepletion therapies, such as chemotherapy and radiotherapy, have been established to augment antitumor immunity. Naïve T cells elicit effector-like phenotypes and functions during recovery from lymphopenia. We and others have repeatedly demonstrated that transfer of naïve T cells into lymphopenic-tumor bearing ...
Miho Takahashi +13 more
openaire +1 more source
Abstract Cytotoxic lymphodepletion therapies, such as chemotherapy and radiotherapy, have been established to augment antitumor immunity. Naïve T cells elicit effector-like phenotypes and functions during recovery from lymphopenia. We and others have repeatedly demonstrated that transfer of naïve T cells into lymphopenic-tumor bearing ...
Miho Takahashi +13 more
openaire +1 more source
Anti‐program cell death receptor‐1 induced erythema nodosum
Dermatologic Therapy, 2022Caroline Gerhardt +5 more
openaire +2 more sources
Ipilimumab/programmed-cell-death-1-receptor-antagonists
Reactions Weekly, 2020openaire +2 more sources
Antineoplastics/programmed-cell-death-1-receptor-antagonists
Reactions Weekly, 2022openaire +1 more source
Programmed-cell-death-1-receptor-antagonists /rituximab
Reactions Weekly, 2022openaire +1 more source
Magyar onkologia, 2019
In the past years, immunotherapy emerged as a novel modality of clinical oncology. The development and introduction of immune checkpoint inhibitors required the development of companion diagnostics, the PD-L1 protein immunohistochemical tests. Unfortunately, almost all checkpoint inhibitors were exclusively validated by a specific PD-L1 in vitro ...
Gábor, Lotz +4 more
openaire +1 more source
In the past years, immunotherapy emerged as a novel modality of clinical oncology. The development and introduction of immune checkpoint inhibitors required the development of companion diagnostics, the PD-L1 protein immunohistochemical tests. Unfortunately, almost all checkpoint inhibitors were exclusively validated by a specific PD-L1 in vitro ...
Gábor, Lotz +4 more
openaire +1 more source
Programmed cell-death-1-ligand-1 inhibitors/programmed cell-death-1-receptor antagonists
Reactions Weekly, 2020openaire +1 more source
Pathobiology
Introduction: This study aimed to evaluate the prognostic significance of programmed cell death (PD)-1/PD-ligand 1 (PD-L1), PD-ligand 2 (PD-L2), and fibroblast growth factor receptor 3 (FGFR3) expression in bladder cancer (BC). Methods: A retrospective study was conducted on BC patients who underwent transurethral resection between 2005 and 2014.
Ana Blanca +6 more
openaire +1 more source
Introduction: This study aimed to evaluate the prognostic significance of programmed cell death (PD)-1/PD-ligand 1 (PD-L1), PD-ligand 2 (PD-L2), and fibroblast growth factor receptor 3 (FGFR3) expression in bladder cancer (BC). Methods: A retrospective study was conducted on BC patients who underwent transurethral resection between 2005 and 2014.
Ana Blanca +6 more
openaire +1 more source
Antineoplastics/programmed-cell-death-1-receptor-antagonists
Reactions Weekly, 2023openaire +1 more source